Macrophages need to release the proximal brake to degrade cellular corpses

Dimitris Typas
DOI: https://doi.org/10.1038/s41594-024-01305-7
2024-04-19
Nature Structural & Molecular Biology
Abstract:Writing in Nature , T. Tufan et al. 1 address this gap in knowledge and provide novel functional and mechanistic insight into efferocytosis activation and execution. Assessing the RNA Polymerase II (Pol II) pausing index, the authors show that upon macrophages encountering apoptotic cells, several genes that bear high amounts of Pol II and are paused at promoter-proximal sites during the resting state overcome this block and become increasingly transcribed. Inhibiting the kinase CDK9, which is responsible for release of the paused Pol II, with generic or specific inhibitors, or degrading CDK9 by specific PROTACs (proteolysis-targeting chimeras), leads to inefficient efferocytosis by both mouse and human macrophages. Under physiological conditions, macrophages are heavily outnumbered by apoptotic cells and individual macrophages sequentially remove several dead cells. The authors demonstrate that abrogating promoter-proximal pausing compromises processes such as continuous efferocytosis, among others, by regulating the expression of factors involved in the acidification and processing of dead cells in macrophages. Importantly, other types of phagocytosis, such as Fc receptor-mediated phagocytosis, do not appear to respond to Pol II pause–release inhibitors, indicating the specificity of this response in efferocytosis.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?